Anne Wojcicki has successfully won back control of 23andMe, the DNA testing company she co-founded, in a court-approved sale process. Her nonprofit organization acquired the company for $305 million, outbidding competitors including Regeneron. This marks a significant comeback for Wojcicki, as she takes the reins of the embattled company following its bankruptcy. The successful bid allows Wojcicki to regain access to the genetic data and assets of 23andMe, following a turbulent period for the firm.